Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure

American Journal of Cardiology

Volumn 83, Issue 9, 1999, Pages 1345-1349

  O'Connor, Christopher M ^a   Gurbel, Paul A ^b   Serebruany, Victor L ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PADGEM PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PILOT PROJECTS; PLATELET ACTIVATION; PROSPECTIVE STUDIES;

EID: 0033135060     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00098-3     Document Type: Article

References (30)

1. de Lorgeril M, Loire R., Guidollet J., Boissonnat P., Dureau G., Renaud S. Accelerated coronary artery disease after heart transplantation the role of enhanced platelet aggregation and thrombosis . J Intern Med. 233:1993;343-350.
2. Rich M.W. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 45:1997;968-974.
3. Ip J.H., Stein B., Fuster V., Badimon L. Antithrombotic therapy in cardiovascular diseases. Ann NY Acad Sci. 614:1991;289-311.
4. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins vascular adhesion molecules . FASEB J. 9:1995;866-873.
5. Johnston G.I., Bliss G.A., Newman P.J., McEver R.P. Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem. 265:1990;21381-21385.
6. Walter U.M., Issekutz A.C. Role of E- and P-selectin in migration of monocytes and polymorphonuclear leukocytes to cytokine and chemoattractant-induced cutaneous inflammation in the rat. Immunology. 92:1997;290-299.
7. Gurbel P.A., Serebruany V.L. Myths and realities of plasma P-selectin levels in patients with acute myocardial infarction. Thromb Res. 88:1997;343-344.
8. Andreassen A.K., Nordoy I., Simonsen S., Ueland T., Muller F., Froland S.S., Gullestad L., Aukrust P. Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am J Cardiol. 81:1998;604-608.
9. Oosterga M., Anthonio R.L., de Kam P.J., Kingma J.H., Crijns H.J., van Gilst W.H. Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction. Am J Cardiol. 81:1998;1178-1181.
10. Serebruany V.L., Gurbel P.A., Shustov A.R., Ohman E.M., Topol E.J. Heterogeneity of platelet aggregation and major surface receptor expression in patients presenting with acute myocardial infarction. Am Heart J. 136:1998;398-405.
11. Serebruany V.L., Gurbel P.A., Shustov A.R., Dalesandro M., Gumbs S.I., Grablutz B.S., Bahr R.D., Ohman E.M., Topol E.J. Depressed platelet status in a patient with hemorrhagic stroke following thrombolysis for acute myocardial infarction. Stroke. 29:1998;235-238.
12. Jafri S.M., Ozawa T., Mammem E., Levine T.B., Johnson C., Goldstein S. Platelet function, thrombin, and fibrinolytic activity in patients with heart failure. Eur Heart J. 14:1993;205-212.
13. Negrescu E.V., Sazonova L.N., Baldenkov G.N., Mucharliamov N.M., Mazaev A.V., Tkachuk V.A. Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. Int J Cardiol. 26:1990;175-184.
14. Hendra T.J., Oswald G.A., Yudkin J.S. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabet Res Clin Pract. 59:1988;259-263.
15. Mastroroberto P., Chello M., Perticone F. Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis. Scand J Thorac Cardiovasc Surg. 30:1996;77-81.
16. Erne P., Wardle J., Sanders K., Lewis S.M., Maseri A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb Haemost. 59:1988;259-263.
17. Weiss R.J., Tobes M., Wertz C.E., Smith C.B. Platelet alpha 2 adrenoreceptors in congestive heart failure. Am J Cardiol. 52:1983;101-105.
18. Anfossi G., Trovati M. Role of catecholamines in platelet function pathophysiological and clinical significance . Eur J Clin Invest. 26:1996;353-370.
19. Packer M., O'Connor C.M., Ghali J.K., Pressler M.L., Carson P.E., Belkin R.N., Miller A.B., Neuberg G.W., Frid D., Wertheimer J.H., Cropp A.B., DeMets D.L. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 335:1996;1107-1114.
20. Haywood G.A., Adams K.F. Jr, Gheorghiade M., McKenna W.J. Is there a role for epoprostenol in the management of heart failure? Am J Cardiol. 75:1995;44A-50A.
21. Buerke M., Cyrus T., Darius H. Phosphodiesterase inhibitors piroximone and enoximone inhibit platelet aggregation in vivo and in vitro. Thromb Res. 88:1997;89-98.
22. Torfgard K.E., Ahlner J. Mechanisms of action of nitrates. Cardiovasc Drugs Ther. 8:1994;701-717.
23. 2+mobilization, glycoprotein IIb/IIIa activation, and experimental coronary thrombosis in vivo in dogs are all inhibited by the ionotropic agent amrinone. Circulation. 96:1997;1647-1653.
24. Ambrosioni E., Borghi C. Potential use of ACE inhibitors after acute myocardial infarction. J Cardiovasc Pharmacol. 14:(suppl 9):1989;S92-S94.
25. Gow I.F., Flapan A.D., Morris M., Davies E., Williams B.C., Padfield P.L., Shaw T.R., Edwards C.R. A lack of effect of captopril on platelet aggregation in patients with congestive heart failure. Eur J Clin Pharmacol. 41:1991;47-49.
26. O'Connor C.M., Hathaway W.R., Bates E.R., Leimberger J.D., Sigmon K.N., Kereiakes D.J., George B.S., Samaha J.K., Abbottsmith C.W., Candela R.J., Topol E.J., Califf R.M. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction development of a predictive model . Am Heart J. 133:1997;663-673.
27. D'Agati V. Does aspirin cause acute or chronic renal failure in experimental animals and in humans? Am J Kidney Dis. (suppl 1):1996;S24-S29.
28. Cleland J.G., Morgan K. Inhibition of the renin-angiotensin-aldosterone system in heart failure new insights from basic clinical research . Curr Opin Cardiol. 11:1996;252-252.
29. Jeserich M., Pape L., Just H., Hornig B., Kupfer M., Munzel T., Lohmann A., Olschewski M., Drexler H. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Am J Cardiol. 76:1995;1079-1082.
30. Serebruany V.L., Bahr R.D., O'Connor C.M., Lowry D.R., Gurbel P.A. Antecedent aspirin therapy inhibits baseline platelet status in patients presenting with acute myocardial infarction. Cardiology. 90:1998;37-42.